The use of immunocytochemical study in the cytologic diagnosis of melanoma: Evaluation of three antibodies

Diagnostic Cytopathology

Volumn 41, Issue 2, 2013, Pages 126-130

  Jing, Xin ^a   Michael, Claire W ^a   Theoharis, Constantine G A ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cytology; HMB 45; melan A; melanoma; S 100

Indexed keywords

MELAN A MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HMB 45; PROTEIN S100 MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTODIAGNOSIS; DIAGNOSTIC VALUE; FALSE POSITIVE RESULT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MELANOMA; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ANTIBODIES; HUMANS; IMMUNOHISTOCHEMISTRY; MART-1 ANTIGEN; MELANOMA; MELANOMA-SPECIFIC ANTIGENS; PREDICTIVE VALUE OF TESTS; S100 PROTEINS; SENSITIVITY AND SPECIFICITY;

EID: 84872619994     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.21791     Document Type: Article

References (13)

1. Gupta SK, Rajwanshi AK, Das DK,. Fine needle aspiration cytology smear patterns of malignant melanoma. Acta Cytol 1985; 29: 983-988. (Pubitemid 16169979)
2. Layfield LJ, Glasgow BJ,. Aspiration biopsy cytology of primary cutaneous tumors. Acta Cytol 1993; 37: 679-688. (Pubitemid 23275029)
3. Coulie PG, Brichard V, Van Pel A, et al. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1994; 180: 35-42. (Pubitemid 24181053)
4. Kawakami Y, Eliyahu S, Delgado CH, et al. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc Natl Acad Sci USA 1994; 91: 3515-3519. (Pubitemid 24139460)
5. Ohsie SJ, Sarantopoulos GP, Cochran AJ, Binder SW,. Immunohistochemical characteristics of melanoma. J Cutan Pathol 2008; 35: 433-444. (Pubitemid 351519417)
6. Beaty MW, Fetsch P, Wilder AM, Marincola F, Abati A,. Effusion cytology of malignant melanoma. A morphologic and immunocytochemical analysis including application of the MART-1 antibody. Cancer 1997; 81: 57-63. (Pubitemid 28275329)
7. Sheffield MV, Yee H, Dorvault CC, et al. Comparison of five antibodies as markers in the diagnosis of melanoma in cytologic preparations. Am J Clin Pathol 2002; 118: 930-936. (Pubitemid 37047834)
8. Fetsch PA, Marincola FM, Filie A, Hijazi YM, Kleiner DE, Abati A,. Melanoma-associated antigen recognized by T cells (MART-1): The advent of a preferred immunocytochemical antibody for the diagnosis of metastatic malignant melanoma with fine-needle aspiration. Cancer 1999; 87: 37-42. (Pubitemid 29104352)
9. Cochran AJ, Wen DR,. S-100 protein as a marker for melanocytic and other tumours. Pathology 1985; 17: 340-345. (Pubitemid 16251039)
10. Fetsch PA, Marincola FM, Abati A,. The new melanoma markers: MART-1 and Melan-A (the NIH experience). Am J Surg Pathol 1999; 23: 607-610. (Pubitemid 29214966)
11. Bussolati G, Gugliotta P, Volante M, Pace M, Papotti M,. Retrieved endogenous biotin: A novel marker and a potential pitfall in diagnostic immunohistochemistry. Histopathology 1997; 31: 400-407. (Pubitemid 27505355)
12. Fan Z, van de Rijn M, Montgomery K, Rouse RV,. Hep par 1 antibody stain for the differential diagnosis of hepatocellular carcinoma: 676 tumors tested using tissue microarrays and conventional tissue sections. Mod Pathol 2003; 16: 137-144. (Pubitemid 36245745)
13. Ramos-Vara JA, Miller MA,. Comparison of two polymer-based immunohistochemical detection systems: ENVISION+ and ImmPRESS. J Microsc 2006; 224 (Part 2): 135-139. (Pubitemid 44973558)